FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Binosto (alendronate sodium) filed by Radius Health, Inc., to update the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• BINOSTO (ALENDRONATE SODIUM)

Snippet

SUPPL AP for BINOSTO (ALENDRONATE SODIUM)